The chicken anemia virus-derived Apoptin protein induces tumor-specific apoptosis. Here, we show that recombinant Apoptin protein spontaneously forms noncovalent globular aggregates comprising 30 to 40 subunits in vitro. This multimerization is robust and virtually irreversible, and the globular aggregates are also stable in cell extracts, suggesting that they remain intact within the cell. Furthermore, studies of Apoptin expressed in living cells confirm that Apoptin indeed exists in large complexes in vivo. We map the structural motifs responsible for multimerization in vitro and aggregation in vivo to the N-terminal half of the protein. Moreover, we show that covalently fixing the Apoptin monomers within the recombinant protein multimer by internal cross-linking does not affect the biological activity of Apoptin, as these fixed aggregates exhibit similar tumor-specific localization and apoptosis-inducing properties as non-cross-linked Apoptin. Taken together, our results imply that recombinant Apoptin protein is a multimer when inducing apoptosis, and we propose that this multimeric state is an essential feature of its ability to do so. Finally, we determine that Apoptin adopts little, if any, regular secondary structure within the aggregates. This surprising result would classify Apoptin as the first protein for which, rather than the formation of a well defined tertiary and quaternary structure, semirandom aggregation is sufficient for activity.
Apoptin is a protein from chicken anemia virus (CAV) 1 that induces apoptosis in transformed chicken cells (1) . It has 121 amino acids and no known functional or sequence homologues. When the gene encoding Apoptin is transduced into cultured cells, the expressed Apoptin protein also induces apoptosis in a wide range of transformed human cell lines (2) . However, nontransformed, normal human primary cell types are not killed. Transformed and non-transformed cells differ markedly in the subcellular localization of expressed Apoptin. In transformed cells, Apoptin migrates to the nucleus, whereas in non-transformed cells it is retained mainly within the cytoplasm. Although nuclear localization of Apoptin appears to be essential for apoptosis induction in transformed cells (3) , the presence of Apoptin in the nucleus alone is not sufficient to induce apoptosis in normal cells. 2 Two clusters of basic residues (Lys 82 -Arg 89 , Arg 111 -Arg 120 ) near the C terminus of Apoptin have been implicated as a nuclear localization signal.
To correlate Apoptin's biological activity with its structure and biophysical properties, we studied several bacterially expressed, tagged recombinant Apoptin proteins. First, because maltose-binding protein (MBP) fusion constructs can be effective in solubilizing aggregation-prone recombinant proteins, we constructed N-terminally MBP-tagged Apoptin (4, 5) . Second, because histidine tagging can allow efficient refolding of protein immobilized on Ni 2ϩ -chelating resin (6), we also constructed C-terminally hexahistidine-tagged Apoptin.
MBP-Apoptin fusion constructs were shown to be biologically active and retain their distinct behavior in normal and tumor cells upon microinjection. 3 Here, we addressed Apoptin's biophysical and structural properties and how these relate to its biological function and found it to be biologically active as a higher order multimer. However, no evidence was found for an established regular structure. Table I for the Expressed Constructs)
MATERIALS AND METHODS

Cloning of Apoptin Expression Vectors (See
pET-22bVp3, C-terminal Hexahistidine Fusion of Full-Length Apoptin (Apoptin-H 6 )-The
Apoptin open reading frame (ORF) was amplified by PCR from pET-11aVp3, which contains the Apoptin coding sequence (nucleotides 427-868 in the CAV genome). The purified PCR fragment was cloned at NdeI and NotI in pET-22b (Novagen), in which a T7lac promoter, inducible with isopropyl-␤-D-1-thiogalactoside (IPTG), controls expression.
pET-22bVp3(1-69)H 6 , N-terminal 69 Residues of Apoptin with Cterminal Hexahistidine Tag (Apoptin(1-69)-H 6 )-
The N-terminal domain of Apoptin (ORF nucleotides 1-207) was amplified by PCR and cloned in pET-22b at NdeI and AvaI.
pMalTBVp3, N-terminal Fusion of MBP and Full-length Apoptin (MBP-Apoptin)-The
Apoptin ORF was cloned at 5Ј BamHI and 3Ј SalI in pMalTB, downstream of the Escherichia coli MalE ORF, which codes for MBP. pMalTB is derived from pMal-c2 (New England Biolabs), and the peptide linker between MBP and its fusion partner contains a thrombin consensus site (-LVPR2GS-). Expression is controlled by an IPTG-inducible P tac promoter.
pMalTBVp3dC69H 6 
MBP Fusion of N-terminal 69 Residues of Apoptin with C-terminal Hexahistidine Tag (MBP-Apoptin(1-69)-H 6 )-The
truncated Apoptin(1-69) ORF was amplified from pET-22bVp3(1-* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Contributed equally. ʈ Contributed equally. ‡ ‡ To whom correspondence should be addressed: P. O. Box 9502, 2300 RA Leiden, The Netherlands. Tel.: 31-071-5274213; Fax: 31-071-5274357; E-mail: abrahams@fwncism1.leidenuniv.nl. 1 The abbreviations used are: CAV, chicken anemia virus; CV, column volume; DAPI, 2,4-diamidino-2-phenylindole; DLS, dynamic light scattering; IPTG, isopropyl-␤-D-1-thiogalactoside; mAb, monoclonal antibody; MBP, maltose-binding protein; MM, molecular mass; NES, nuclear export signal; NTA, nitrilotriacetic acid; OG, N-octylthioglucoside; ORF, open reading frame; R H , hydrodynamic radius; PBS, phosphatebuffered saline; CHAPSO, 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonic acid. All clones were confirmed by automated fluorescent sequencing. Table I summarizes the protein constructs we generated.
Bacterial Expression of Apoptin Constructs
Medium to large scale expression was performed in either of two set-ups as follows: 1) 500 ml of expression medium in a 2-liter threebaffled flask (Bellco Glass Inc.) (250 rpm, 37°C); or 2) a 1.8-liter bench-top fermentor (Biospec Products Inc.) (maximum agitation and aeration, 37°C). In both cases, a few drops of anti-foam A (Sigma) were added directly prior to inoculation. For expression of MBP fusion proteins, the LB medium was supplemented with 0.2% glucose to suppress the expression of endogenous E. coli ␣-amylases, which might interfere with affinity purification of the fusion protein. E. coli BL21(DE3) CaCl 2 -competent cells were transformed with one of the Apoptin constructs described above. A single transformant colony was grown overnight in LB (ϩ0.2% glucose), supplemented with 200 g/ml carbenicillin (Duchefa) and if necessary with 0.1 mM ZnSO 4 . After resuspending the cells in fresh medium, a volume of expression culture (LB ϩ 0.2% glucose, ϩ100 g/ml carbenicillin, Ϯ0.1 mM ZnSO 4 ) was inoculated 1 in 50. Upon reaching an A 600 of ϳ0.8 (2 to 3 h), expression was induced by adding 1 mM IPTG. After 3 to 4 h (final A 600 ϭ 3 to 5), the cells were harvested and lysed using a BeadBeater (Biospec Products Inc.). Lysis buffers were as follows: 1) for MBP, MBP-Apoptin, MBP-Apoptin(1-69)-H 6 , and MBP-Apoptin(66 -121): 25 mM HEPES, pH 7.4, 500 mM NaCl, 10% glycerol, 5 mM reduced glutathione (GSH) (Sigma), 2 mM MgCl 2 , 1ϫ protease inhibitor mixture (EDTA-free) (Roche Molecular Biochemicals), DNase I (10 to 50 g/ml) (Roche Molecular Biochemicals); 2) for Apoptin-H 6 : 1ϫ PBS, 2 mM MgCl 2 , 1 mM phenylmethylsulfonyl fluoride (Invitrogen), DNase I; 3) Apoptin(1-69)H 6 , 50 mM KPO 4 , pH 7.4, 2.5 mM imidazole (Fluka), 300 mM NaCl, 2 mM MgCl 2 , DNase I, protease inhibitor mixture, 2.5 mM GSH. The glass bead/lysate slurry was filtered (Whatmann 3MM) and centrifuged at 29,000 ϫ g for 15 min. Finally, lysates were fully cleared by filtering over a 0.22-m filter.
Purification of E. coli-expressed Protein
MBP-Apoptin and MBP-Apoptin(66 -121)-
The cleared lysate of a 1-liter expression culture was passed twice over an amylose column (2.5 ϫ 20 cm), equilibrated in 20 mM HEPES, pH 7.4, 500 mM NaCl, 10% glycerol, 1 mM EDTA, or 0.1 mM ZnSO 4 , under gravity flow at 4°C. The column was washed with 5 column volumes (CV) of 20 mM HEPES, pH 7.4, 1 M NaCl, 1 mM EDTA, or 0.1 mM ZnSO 4 followed by 5 CVs of 20 mM HEPES, pH 7.4, 50 mM NaCl, 1 mM EDTA, or 0.1 mM ZnSO 4 . The column was then eluted with 20 mM HEPES, pH 7.4, 50 mM NaCl, 1 mM EDTA, or 0.1 mM ZnSO 4 , 10 mM maltose (Fluka). For all MBP fusion proteins, phenylmethylsulfonyl fluoride (0.5 mM) was directly added to the eluate to prevent degradation by traces of E. coli proteases. After filtering, the eluate was loaded on an analytical cation exchange column (UNO-S12) (Bio-Rad), equilibrated at 3 ml/min in 20 mM HEPES, pH 7.4, 50 mM NaCl, 1 mM EDTA, or 0.1 mM ZnSO 4 . After extensive washing, the column was eluted with a 200-ml linear gradient (50 -1000 mM NaCl, 5-ml fractions). Appropriate fractions were pooled and dialyzed against PBS (CelluSep T1 membranes, molecular mass cut-off 3.5 kDa; Membrane Filtration Products Inc.). MBP-Apoptin and MBPApoptin(66 -121) were concentrated on a Biomax 5K or 10K Ultrafree spin filter (Millipore) to 40 and 10 mg/ml, respectively. As a rule, solutions of MBP-Apoptin fusion proteins were never subjected to freeze/thawing and stored at 4°C for up to one month. We noticed that MBP-Apoptin, but not MBP alone, formed insoluble aggregates when incubated at ϳ1 mg/ml in PBS, 1 mM EDTA, 1% (32 mM) N-octylthioglucoside (OG) (Roche Molecular Biochemicals) for 1 h at 30°C (data not shown). Only a small amount of MBP-Apoptin remained in solution under these conditions, as tested by Bradford protein assay (Bio-Rad). We did not observe such an effect when OG was replaced by CHAPSO (0.5%; Sigma) or Triton X-100 (1%; Roche Molecular Biochemicals).
Apoptin-H 6 -Starting with a 1.8-liter expression, the pellet after lysis was resuspended in PBS, 0.5% Triton X-100 (Roche Molecular Biochemicals) and stirred at room temperature for 1 h. The suspension was then centrifuged at 29,000 ϫ g for 20 min, after which the inclusion bodies were washed once with PBS. They were then resuspended in 50 mM HEPES, pH 7.4, 20 mM glycine, 2 mM EDTA, 20 mM DL-dithiothreitol, 8 M urea (molecular biology grade) (Invitrogen) and stirred overnight at 4°C. The cleared supernatant was then loaded on a UNO-S12 column, equilibrated at 3 ml/min in 20 mM KPO 4 , pH 7.4, 2.5 mM imidazole, 2 mM GSH, 6 M urea. After washing, the column was eluted with a 160-ml linear gradient (0 -1 M NaCl, 5-ml fractions). Appropriate fractions were pooled and stored at Ϫ80°C if not used immediately afterward. UNO-S12-cleaned Apoptin-H 6 was mixed with a suspension of 10 to 15 ml of Ni 2ϩ -nitrilotriacetic acid (NTA)-agarose (Qiagen), equilibrated in 20 mM KPO 4 , pH 7.4, 2.5 mM imidazole, 500 mM NaCl, 2 mM GSH, 6 M urea, and stirred at 4°C for 2 h. The resin was packed into a column, which was subsequently washed with 5 CVs of 20 mM KPO 4 , pH 7.4, 20 mM imidazole, 500 mM NaCl, 2 mM GSH, 6 M guanidinium hydrochloride (Invitrogen). The denaturant was then removed, in one step, by washing with 5 CVs of 20 mM KPO 4 , pH 6.5, 5 mM imidazole, 400 mM NaCl, 2 mM GSH, 2 mM MgCl 2 . The protein was eluted with the same buffer, supplemented with 500 mM imidazole. All Ni 2ϩ traces were removed completely by adding 5 mM EDTA to the eluted protein and dialyzing it against 20 mM KPO 4 , pH 6.5, 400 mM NaCl, 2 mM MgCl 2 . Refolded Apoptin-H 6 was concentrated on a Centricon YM3 filter (Amicon) to 10 mg/ml. Solutions of refolded Apoptin-H 6 were never subjected to freeze/thawing and were stored for up to one month at 4°C.
MBP-Apoptin(1-69)-H 6 -
The cleared lysate of a 1-liter expression was applied to an amylose column, as described above. After washing, the fusion protein was eluted in 50 mM KPO 4 , pH 7.4, 2.5 mM imidazole, 300 mM NaCl, 10 mM maltose. The eluate was filtered and loaded on a Ni 2ϩ -NTA-agarose column (1.5 ϫ 5 cm), which was washed with 50 mM KPO 4 , pH 7.4, 30 mM imidazole, 300 mM NaCl. The protein was eluted with 50 mM KPO 4 , pH 7.4, 300 mM imidazole, 300 mM NaCl and dialyzed against PBS, 0.5 mM EDTA.
MBP-Non-fused MBP was purified from IPTG-induced E. coli BL21(DE3) transformed with pMalTB. After binding to amylose, the column was washed with 20 mM Tris-HCl, pH 7.4, 1 mM EDTA. MBP was then eluted with 20 mM Tris-HCl, pH 7.4, 1 mM EDTA, 10 mM maltose and loaded on an analytical anion exchange column (UNO-Q1; Bio-Rad). The column was eluted with a 20-ml linear gradient (0 -1 M NaCl, 1-ml fractions). MBP-containing fractions (1 to 5 mg/ml) were dialyzed against PBS and then flash-frozen in liquid nitrogen and stored at Ϫ20°C.
Apoptin )-H 6 -The cleared lysate of a 1-liter culture was loaded on a 5-ml Ni 2ϩ -NTA-agarose (1.5 ϫ 3 cm) column. The column was washed with lysis buffer, supplemented with 100 mM imidazole, and then eluted with 20 mM KPO 4 , pH 7.4, 500 mM imidazole, 500 mM NaCl. After adding EDTA, the eluate was dialyzed to 20 mM KPO 4 , pH 6.5, 400 mM NaCl, 2 mM MgCl 2 . Apoptin(1-69)-H 6 was concentrated on a Centricon YM3 filter (Amicon) to 10 mg/ml. 
Protein Concentration Determination
All protein concentrations were determined from A 280 . The extinction coefficient of MBP-Apoptin and Apoptin-H 6 at 280 nm (mg/ml/cm) was 1.0 Ϯ 0.1 and 0.10 Ϯ 0.01, respectively. The molecular mass of MBPApoptin and Apoptin-H 6 was taken as 55.8 and 14.5 kDa per monomer, respectively.
Size Exclusion Chromatography
Samples were run as follows: 1) Sephacryl S100 HR (1.0 ϫ 48 cm; Amersham Biosciences), which was calibrated with blue dextran (Ͼ2 MDa; Sigma) and Ponceau S (0.76 kDa; Sigma) at a flow rate of 11.5 cm/h in a sample load of 500 l; or 2) Superose 6 HR 10/30 (Amersham Biosciences), which was calibrated with a size exclusion chromatography calibration kit (Bio-Rad) (670, 158, 44, 17, and 1.35 kDa) at a flow rate of 0.2 to 0.4 ml/min in a sample load of 100 l. For the second set of conditions (Superose 6 HR), linear regression analysis of the elution profile of the calibration run yielded log[molecular mass (kDa)] ϭ 7.773 Ϫ (0.365)[ml eluens].
Dynamic Light Scattering
All dynamic light scattering measurements were recorded on a DynaPro-MS/X (Protein Solutions Inc.) at room temperature. Bovine serum albumin was used as a control (0.5 mg/ml in PBS, 0.5 mM EDTA). MBP-Apoptin was measured at 10 M (monomer concentration) in PBS, 0.5 mM EDTA, and refolded Apoptin-H 6 at 35 M (monomers) in 20 mM KPO 4 , pH 6.5, 400 mM NaCl, 2 mM MgCl 2 . Per experiment, between 20 and 40 measurements (10-s intervals) were collected. The hydrodynamic radius of the particle (R H ) was determined by averaging the results of at least three separate experiments. Protein molecular mass was estimated from the R H by the equation
Circular Dichroism Spectroscopy
Far-UV circular dichroism spectra were recorded on a Jasco J-715 spectrometer. Spectrometer settings were as follows: wavelength range, 190 -260 nm; cell width, 1 mm; scan speed, 50 nm/min; response time, 1.0 s; bandwidth, 1.0 nm; pitch, 0.1 nm. Spectra were averaged over eight acquisitions. Throughout the measurements, the spectrometer was flushed with O 2 -free N 2 at 10 liters/min. Cell temperature was maintained at 20°C by a Jasco PTC-348WI Peltier element. MBPApoptin was dialyzed to 10 mM KPO 4 , pH 6.5, 0.1 mM EDTA, or 0.1 mM ZnSO 4 , and refolded Apoptin-H 6 was dialyzed to 20 mM KPO 4 , pH 6.5, 1 mM MgSO 4 , or 0.1 mM ZnSO 4 . All samples and buffers were filtered and degassed directly prior to measurement.
Fluorescence Measurements
Fluorescence emission and excitation spectra were recorded on a PerkinElmer Life Sciences LS-50B. Fluorimeter settings were as follows: slit width, 6 nm; scan speed, 120 nm/min; excitation wavelength, 280 nm. Final spectra were obtained by averaging three separate spectra. Background emission and excitation spectra were recorded of the respective filtered buffers. The concentration of refolded Apoptin-H 6 was 55 M (monomer concentration) in refolding buffer (20 mM KPO 4 , pH 6.5, 400 mM NaCl, 2 mM MgCl 2 ). The concentration of free tyrosine (L-Tyr) was 7.5 M in Apoptin-H 6 dialysis buffer, pH 6.5, and 500 M in 50 mM Na 3 PO 4 , pH 12, 1 mM EDTA.
Scanning Force and Electron Microscopic Analysis
Biotin Labeling-Fresh MBP-Apoptin (20 mg/ml, 0.1 M NaHCO 3 , pH 8.3) was incubated with 5 mM sulfo-NHS-LC-biotin (Molecular Probes, Inc.) at room temperature for 3 h. The reaction was terminated by adding 10 mM ethanolamine. To remove unincorporated label, the labeled protein was passed over a PD-10 desalting column (Amersham Biosciences), equilibrated in 20 mM HEPES, pH 7.4, 0.1 mM EDTA.
Electron Microscopy-Both labeled and unlabeled MBP-Apoptin (30 mg/ml, in 20 mM HEPES, pH 7.4, 0.1 mM EDTA) were filtered over 0.22-m spinfilters (Ultrafree-MC; Millipore) and adsorbed to a carboncoated polioform layer grid. Both samples were incubated with concentrated streptavidin-gold conjugate (gold particle diameter, 5 nm) (Kirkegaard & Perry Laboratories Inc.) and stained with 3% uranyl acetate. Electron microscopy was performed on a Philips TEM 410 transmission electron microscope.
Scanning Force Microscopy-90 ng of purified MBP-Apoptin (in 10 l of 5 mM HEPES, pH 7.9, 3 mM KCl, 5.5 mM MgCl 2 ) was incubated at 37°C for 15 min and then deposited on a disc of freshly cleaved mica (Ted Pella Inc.). After 20 s, the mica was gently rinsed with high pressure liquid chromatography water. Excess water was removed, and the disc was dried with a steady flow of 0.22 m of filtered air. Images were acquired on a Nanoscope IIIa (Digital Instruments Inc.), operating in tapping mode in air with a type E scanner. Silicon tips were obtained from Digital Instruments.
SDS-PAGE and Western Blotting
SDS-PAGE-Protein samples were run on 7.5-15% SDS-PAGE gels, either under reducing or non-reducing conditions, i.e. with or without ␤-mercaptoethanol in the sample buffer. 1ϫ SDS-PAGE sample buffer contained 20 mM Tris-HCl, pH 6.8, 0.01% bromphenol blue, 1% SDS, 10% glycerol, 1% ␤-mercaptoethanol. Gels were stained with Coomassie Brilliant Blue (Bio-Rad).
Western Blotting and Dot Blotting-Samples were run on SDS-PAGE and blotted onto Immunoblot polyvinylidene difluoride membranes (Bio-Rad) or dot blotted directly onto polyvinylidene difluoride after denaturation in 1ϫ SDS-PAGE sample buffer (95°C for 5 min). Blots were probed with the anti-Apoptin monoclonal antibody 111.3 (epitope, residues 18 to 23) (2) or with the polyclonal anti-Apoptin antibody ␣VP3-C, which has an epitope range comprising residues 79 to 90 (9) . Blots were subsequently incubated with an appropriate horseradish peroxidase-conjugated secondary antibody and developed by enhanced chemiluminescence.
Fluorescent Zinc Assay
Calibration Curve-A concentration range of ZnSO 4 (1 to 20 M) (Fluka) was prepared in assay buffer (50 mM HEPES, pH 7.4, 0.2% SDS), to which 200 nM FluoZin-1 (Molecular Probes) was added to from a 2 mM stock solution in water. Fluorescence spectra were recorded after 15 min of equilibration at room temperature. Spectra were adjusted for background fluorescence, which was determined from a sample of FluoZin-1, to which 5 mM EDTA had been added. Fluorimeter settings were as follows: slit width, 4 nm; scan speed, 120 nm/min; excitation wavelength, 495 nm.
Sample Preparation-Protein samples were as follows. 1) MBP-Apoptin was expressed in the presence of 0.1 mM ZnSO 4 and purified without using EDTA. 2) MBP-Apoptin, expressed without additional Zn 2ϩ and treated with EDTA, was incubated with a 10-fold molar excess of ZnSO 4 overnight at 4°C (in PBS). Both samples were desalted on a PD-10 column, equilibrated in 50 mM HEPES, pH 7.4, and then denatured in 0.5% SDS (95°C for 5 min). After cooling to room temperature, the samples were diluted in assay buffer to 10 M final protein concentration (monomers) and 0.2% final SDS concentration. Fluorescence spectra were recorded after addition of FluoZin-1.
Fluorescent Labeling and Chemical Cross-linking
Fluorescent Labeling-The number of solvent-exposed Cys residues per MBP-Apoptin monomer was determined using 5,5Ј-dithiobis(2-nitrobenzoic acid) (Sigma) (10) . Fresh MBP-Apoptin (5 mg/ml, PBS) was incubated with 2 mM of fluorescein-5-maleimide (Molecular Probes), diluted from a freshly prepared 20 mM stock solution in 50 mM Na 3 PO 4 , pH 12, and incubated overnight at 4°C in the dark. The labeling reaction was stopped by adding 10 mM ␤-mercaptoethanol, after which unincorporated label was removed by passing the protein over a PD-10 column (Amersham Biosciences), equilibrated in PBS. The level of label incorporation was determined from the equation,
where A is the absorbance of the label, C is the concentration of labeled protein (in mg/ml), EC is the molar extinction coefficient of the label (cm/M), and MM is the molecular mass of the protein (in Da).
Cross-linking-Following labeling with fluorescein-5-maleimide, the protein (3 mg/ml) was incubated with 0.05% glutaraldehyde, diluted from a 8% stock solution in water (grade I; Sigma), for 3 min at 30°C (in the dark). The reaction was stopped by adding 50 mM ␤-alanine (Fluka). After 20 min, the protein was passed over a PD-10 column, equilibrated in PBS.
Incubation of Recombinant MBP-Apoptin in Saos-2 and VH10 Lysates in Low Detergent Buffer
Saos-2 cells, which are human tumor cells derived from osteosarcoma, and VH10 cells, which are normal human fibroblasts, were grown to around 50% confluency. The cells were washed with cold PBS and harvested in ice-cold 25 mM HEPES, pH 7.4, 150 mM KCl, 2 mM MgCl 2 , 5 mM dithiothreitol, 2.5 mM benzamidine hydrochloride (Sigma), 0.25% CHAPSO (Sigma). The suspensions were sonicated on ice, after which insoluble material was removed by centrifugation at 29,000 ϫ g for 20 min. After determining the respective protein concentrations, MBPApoptin was added to 5% (w/w), which was estimated to be the average ratio of MBP-Apoptin to cytoplasmic protein in microinjected cells (7, 8) .
Samples were incubated for 30 min at 30°C, in the presence of 1 mM ATP and 20 mM MgCl 2 , and for 2 and 24 h at 4°C, without additives. Following incubation, samples were fractionated on Superose 6 HR 10/30. Prior to fractionation, any precipitated material was pelleted by centrifugation at 29,000 ϫ g for 20 min, after which the pellets were washed with lysis buffer. All pellets and fractions were dot blotted, using 10 l per sample, as described above. Dot blots were probed with mAb 111.3.
Microinjection
Saos-2 and VH10 cells were cultured in Dulbecco's modified Eagle's medium containing 10% fetal calf serum, penicillin and streptomycin (Invitrogen). Cells were seeded in 35-mm tissue glass-bottomed culture dishes and grown to 30 to 40% confluency prior to microinjection. During microinjection, cells were incubated in RPMI 1640 medium (25 mM HEPES, pH 7.2, 5% fetal calf serum, penicillin, and streptomycin) at 37°C. Cells were returned to Dulbecco's modified Eagle's medium directly after microinjection. Microinjection was performed with 0.5-m microneedles (sterile femtotips II; Eppendorf) under an inverted microscope (Axiovert 135 TV; Zeiss), equipped with a programmable microinjector (IM 300; Narishige Co.) and a joystick hydraulic micromanipulator (MMO-202; Narishige Co.). Fluorescein-labeled, cross-linked MBP-Apoptin (3 mg/ml, in PBS) was combined with lysine-fixable rhodamine-dextran (Molecular Probes) to mark injected cells. Directly prior to injection, protein samples were filtered over 0.22 m or centrifuged at 15,000 ϫ g for 15 min. An injection pressure of 0.5 to 1.0 pounds/square inch, and an injection time of 0.2 to 0.5 s was used. For analysis of apoptotic activity, 100 cells were injected per dish.
Transient Transfection and Protein Extraction
Saos-2 cells were seeded in 9-cm plates at 20% confluency and transfected with 7 g of DNA using FuGENE 6.0 (Roche Molecular Biochemicals) according to the manufacturer's protocol, pcDNA3.1mychis(Ϫ)-MVp3, pcDNA3.1mychis(Ϫ)-MVp3 (80 -121) (3:1 l/g FuGENE:DNA ratio), or mock-transfected. For analysis of protein solubility, cells were trypsinized and washed with 1ϫ PBS 2 days after transfection. Cells were pooled from two dishes per construct and resuspended in 200 l of 20 mM Tris-HCl, pH 7.5, 250 mM NaCl, 5 mM EDTA, 0.1% Triton X-100, 20 mM ␤-glycerophosphate, 5 mM NaF, 5 mM GSH, 2ϫ protease inhibitor mixture (Roche Molecular Biochemicals), and left on ice for 30 min. Cell debris and the bulk of the insoluble protein fraction were pelleted by centrifugation at 10,000 ϫ g for 20 min at 4°C. After separating supernatant (S10) and pellet (P10), we centrifuged the supernatant at 30,000 ϫ g for 20 min, yielding S30 and P30. Protein samples were Western blotted, as described above, and blots were stained with ␣VP3-C.
(Immuno)fluorescence Microscopy
Microinjection-2 and 24 h after injection, cells were fixed sequentially with PBS, 1% freshly prepared formaldehyde (10 min) and then 100% cold MeOH (5 min) and 80% cold acetone (2 min). Fluoresceinlabeled, cross-linked MBP-Apoptin was detected by direct fluorescence. The apoptotic condition of individual cells was deduced from their nuclear morphology after staining with 2,4-diamidino-2-phenylindole (DAPI).
Transient Transfection-In a parallel experiment, Saos-2 cells were grown on coverslips in 9-cm plates and transfected as described above, fixed using fresh 1:1 methanol:acetone for 5 min, and stained with a mouse monoclonal antibody that recognized MBP (clone R29.6; Abcam). An appropriate fluorescein isothiocyanate-labeled secondary antibody was added, and the cells were mounted in DAPI/DABCO(1,4-diazabicyclo[2.2.2]octane)/glycerol. Again, apoptotic cells were scored on the basis of their nuclear morphology. Detection of MBP-Apoptin with ␣VP3-C produced comparable results. eric complex, with a molecular mass of 2.5 Ϯ 0.3 MDa, on an analytical size exclusion chromatography column (Superose 6 HR 10/30) (Fig. 1, A and B) . The molecular mass of the MBPApoptin monomer is 56 kDa; see Table I . Analysis of purified MBP-Apoptin by scanning force microscopy and electron microscopy showed a uniform population of globular particles with a radius of ϳ40 nm (Fig. 2, A and B) . Dynamic light scattering (DLS 1 ) confirmed that the MBP-Apoptin complex is present as a single solute species with an average R H of 17.9 Ϯ 2.0 nm, which corresponds to a diameter of 36 Ϯ 4.0 nm and an estimated molecular mass of 2.9 Ϯ 0.6 MDa. The variation in the average R H of the MBP-Apoptin particle among four separate protein batches remained within experimental error (16 to 20 nm). The multimerization of MBP-Apoptin was independent of the protein concentration (0.5 to 25 mg/ml), ionic strength (up to 0.4 M NaCl), and the presence of detergent (0.5% CHAPSO or 1% Triton X-100). Despite the high stability of the complex, there were no covalent bonds between individual MBP-Apoptin monomers, because only monomers could be observed upon boiling in SDS followed by SDS-PAGE under nonreducing conditions (Fig. 3A) . We noticed that MBP-Apoptin precipitated nearly completely when incubated in 1% OG (in PBS), a non-denaturing detergent, for 1 h at 30°C (data not shown). Because MBP alone did not precipitate under the same conditions, it appeared that N-octylthioglucoside selectively destabilized the Apoptin multimer. This result suggests that hydrophobic interactions play an essential role in the formation of Apoptin protein multimers.
RESULTS
Recombinant Apoptin Forms
In addition to the full-length MBP-Apoptin fusion protein, which migrated as a 58.5-kDa species on SDS-PAGE, three less-abundant expression products of 56.7, 53.3, and 50.1 kDa consistently co-purified with the MBP-Apoptin multimer. All three could be detected with the anti-Apoptin mAb 111.3 (Fig.  3B) . These products could not be removed under native conditions, demonstrating that the degradation products were still incorporated into the MBP-Apoptin complex. The linker peptide that connects the MBP and Apoptin moieties contains a thrombin cleavage site. When the fusion protein was digested with thrombin, cleaved-off MBP was released from the complex, whereas the Apoptin moieties remained part of it, indicating that the multimerization behavior of MBP-Apoptin depended entirely on the Apoptin moiety (data not shown).
Apoptin-H 6 -In E. coli, inclusion bodies of Apoptin-H 6 were expressed with a yield of up to 40 mg per liter of culture. Manipulating growth or lysis conditions did not increase the solubility of Apoptin-H 6 . After solubilization in 8 M urea, Apoptin-H 6 was purified to ϳ90% homogeneity by cation exchange chromatography under denaturing conditions (6 M urea). It could be refolded with a net efficiency of ϳ50% in a single step while bound to Ni 2ϩ -NTA-agarose. On Superose 6 HR 10/30, refolded Apoptin-H 6 migrated as a single species with a molecular mass of 400 Ϯ 50 kDa, independent of protein concentration (1 to 7 mg/ml) (Fig. 1C) . The molecular mass of the Apoptin-H 6 monomer is 14.5 kDa; see Table I . The two additional peaks of 30 and 10 kDa in the Superose 6 elution profile were unlikely to contain Apoptin as they were not recognized by the Apoptin-specific antibody mAb 111.3. DLS confirmed the particle size, indicating a single solute species with an R H of 8.5 Ϯ 1.0 nm, corresponding to a molecular mass of 500 Ϯ 100 kDa. The variation in complex size among three separate protein batches remained within experimental error (8 to 10 nm).
Like the MBP-Apoptin complex, the Apoptin-H 6 complex was non-covalent, as shown by non-reducing SDS-PAGE (Fig. 3C) . A number of additional species migrating with apparent molecular masses of 8, 34, and 48 kDa could be detected by mAb 111.3 (Fig. 3D) . The smallest mAb 111.3-reactive species (8 kDa) corresponded to an N-terminal fragment lacking the Cterminal hexahistidine tag. As in the MBP-Apoptin complexes, fragments truncated at the C terminus remained associated and co-purified.
Mapping the Regions Required for Multimerization: N-and C-terminal Domains of Apoptin-
To evaluate the ability of fragments of Apoptin to form multimers, Apoptin's N-terminal 69 residues and C-terminal 56 residues (66 -121) were cloned separately as MBP fusion proteins. The MBP-Apoptin(1-69) fusion also contained a C-terminal hexahistidine tag to facilitate further purification. In E. coli, soluble MBP-Apoptin(1-69)-H 6 was expressed with yields of up to 100 mg per liter of culture. It displayed the same elution profile on size exclusion chromatography as did full-length MBP-Apoptin(1-121), indicating that the complex is about 2.5 MDa in size (Fig. 1D) . As with the full-length MBP-Apoptin complex, Apoptin(1-69)-H 6 with its MBP moiety cleaved off co-eluted with the intact fusion protein (data not shown).
In E. coli, soluble Apoptin(1-69)-H 6 was expressed with a yield of up to 2 mg per liter of culture. After Ni 2ϩ -NTA-agarose purification, the homogeneity of Apoptin(1-69)-H 6 was ϳ80%. When the Ni 2ϩ -NTA-agarose eluate was fractionated on a Sephacryl S100 HR gel filtration column, the Apoptin(1-69)-H 6 could only be recovered from the void volume. This   FIG. 2 . Analysis of MBP-Apoptin multimers by scanning force microscopy and electron microscopy. The Apoptin multimeric complex is globular and has a diameter of about 40 nm. A, scanning force microscopy analysis was as follows: MBP-Apoptin (in 5 mM HEPES, pH 7.9, 5.5 mM MgCl 2 , 3 mM KCl) was deposited onto freshly cleaved mica and then air-dried. The surface area is 3 ϫ 3 m. Height is indicated in grayscale, and the bar is from 0.0 (black) to 1.5 nm (gray). B, electron microscopy analysis was as follows: biotin-labeled MBP-Apoptin (30 mg/ml) was adsorbed onto a carbon-coated polioform layer grid and incubated with a streptavidin-gold conjugate (diameter gold particles ϭ 5 nm). Between 5 and 10% of globules showed gold binding, whereas a-selective binding was less than 0.1%. Negative staining was done with 3% uranyl acetate. Bar represents 100 nm. finding indicated that Apoptin(1-69)-H 6 formed a complex of at least 100 kDa in size under non-denaturing conditions (data not shown). The molecular mass of the Apoptin(1-69)-H 6 is 8.3 kDa; see Table I. MBP-Apoptin(66 -121) was expressed in soluble form to ϳ50 mg per liter of culture. Purified MBP-Apoptin(66 -121) migrated at ϳ50 kDa on SDS-PAGE. In contrast to the full-length fusion protein, MBP-Apoptin(66 -121) consisted exclusively of two species of ϳ200 and 60 kDa, which may correspond to an equilibrium between a monomer and a di-or trimer (Fig. 1E) . The molecular mass of MBP-Apoptin(66 -121) is 49 kDa; see Table I . DLS analysis indicated that there was only one solute species present, with an R H of 4.6 Ϯ 0.8 nm, which corresponds to an average molecular mass of 120 Ϯ 50 kDa. Regardless of the precise nature of the two species, this result shows that the C-terminal domain of Apoptin on its own is unable to form the type of higher order multimers such as MBP-Apoptin(1-121) does. Taken together, these results demonstrate that the Nterminal 69 residues of Apoptin contain sufficient structural elements to account for its multimerization behavior.
Apoptin Has Little if Any Ordered Structure
Next, we examined whether recombinant Apoptin protein harbors any secondary or tertiary structure, using circular dichroism (CD) and fluorescence spectroscopy.
CD Spectroscopy-The far-UV CD spectrum of refolded Apoptin-H 6 (Fig. 4A) showed a very small mean residue ellipticity ([] MRE ) at 222 nm, indicating that the protein was nearly devoid of ␣-helical structure (11). Refolded Apoptin-H 6 also contained little ␤-sheet structure, which could be deduced from a small positive [] 195 and a small negative [] 216 (11) . The k2d program for protein secondary structure prediction from CD spectra (12) could not assign any ␣-helical or ␤-sheet structure. Although refolded Apoptin-H 6 had little if any secondary structure, it did not adopt a fully random conformation, which would be characterized by a large negative [] 190 -200 (11) . It is possible that the flexibility of the polypeptide is restricted because of the high Pro content of Apoptin (12.4%). The negative [] 200 -210 could even suggest the presence of a poly-L-proline helix, although an accompanying small positive [] 228 was absent (13) . Nevertheless, some of Apoptin's Pro residues may adopt a helix-like conformation. The broad negative [] MRE of Apoptin between 210 and 230 nm was reminiscent of CD spectra reported for ␤-turn-or -hairpin-containing peptides (14, 15) . However, the geometry of residues involved in ␤-turns and -hairpins can vary considerably, making their net contribution to a CD spectrum poorly quantifiable. In general, the CD spectrum of refolded Apoptin-H 6 was very similar to that of proteins that are mostly unstructured (16 -19) .
The CD spectrum of MBP-Apoptin confirmed these observations, being not significantly different from that of MBP on its own (Fig. 4B) (20, 21) . First, this result shows that the Apoptin moiety did not perturb the folding of MBP. Second, it demonstrates that Apoptin did not contribute significantly to the secondary structure content of the fusion protein. This is consistent with the very low overall [] MRE of refolded Apoptin-H 6 . We conclude that Apoptin displays very little regular secondary structure, but we cannot exclude that some residues adopt a ␤-strand or -turn conformation.
Intrinsic Fluorescence of Tyr 95 -Even though Apoptin did not appear to adopt a well defined fold, the Apoptin polypeptide might still display a certain degree of intra-or intermolecular order within the multimeric complex. Because Apoptin-H 6 does not contain any Trp residues, the intrinsic fluorescence of its single Tyr 95 can act as a structural probe (22, 23) . Tyr 95 is outside the multimerization domain defined by Apoptin's Nterminal residues. The excitation spectrum of Tyr 95 in refolded Apoptin-H 6 was very similar to that of protonated L-Tyr(-OH), with excitation maxima at 280 and 275 nm, respectively (Fig.  5A) . However, the fluorescence emission spectrum of Apoptin's Tyr 95 at pH 6.5 closely resembled that of deprotonated, free tyrosine (L-Tyr(-O Ϫ )) at pH 12 (Fig. 5B ). This apparent discrepancy can be explained by the effect that excitation has on the pK a of the Tyr side chain; the pK a of Tyr(-OH) is near 10 in the ground state but decreases to ϳ4 upon excitation (24, 25) . Because the emission spectrum of refolded Apoptin-H 6 was almost entirely devoid of Tyr(-OH) fluorescence, an efficient proton transfer to a nearby proton-accepting group (Glu, Asp, or His) must have occurred upon excitation of Tyr 95 . This result indicates that Tyr 95 was hydrogen bonded. The fluorescence yield of Tyr 95 was increased by a factor of 4 to 5 relative to fully deprotonated and solvent-exposed L-Tyr(-O Ϫ ) (at pH 12), which indicates that Tyr 95 was at least partially protected from the solvent. The presence of an internal hydrogen bond involving the side chain of Tyr 95 suggests that at least one region of the Apoptin polypeptide was able to adopt a more ordered conformation.
Apoptin . Although this arrangement does not bear a clear resemblance to any known metal-binding motifs, it is possible that binding of a metal ion by Apoptin influences its secondary structure content or multimerization behavior. The most obvious ligand for this motif would be Zn 2ϩ . Including Zn 2ϩ in both the expression medium and purification buffers did not affect the expression level, solubility, or net yield of MBP-Apoptin and Apoptin-H 6 . Furthermore, the CD spectra of MBP-Apoptin and Apoptin-H 6 were not significantly altered by the presence of Zn 2ϩ added either after purification or during expression. The presence of Zn 2ϩ affected neither efficiency nor specificity of thrombin digestion of MBP-Apoptin nor the intrinsic fluorescence of refolded Apoptin-H 6 . Finally, an assay based on the strong increase in fluorescence upon Zn 2ϩ binding of the watersoluble Zn 2ϩ -selective chelating dye FluoZin-1 (26) indicated that MBP-Apoptin expressed and purified in the presence of 
MBP-Apoptin Expressed in Tumor Cells Exists in an Aggregated State
Having established that recombinant Apoptin protein exists exclusively as a remarkably homogenous and highly stable aggregate in vitro, we evaluated the aggregation state of ectopically expressed MBP-Apoptin in human tumor cells (Saos-2). As our data on recombinant MBP-Apoptin(66 -121) and MBP-Apoptin(1-69)-H 6 suggested that Apoptin's multimerization domain resided in its N-terminal domain, we expressed MBP-Apoptin(80 -121) to compare the appearance of aggregated full-length MBP-Apoptin with that of a truncated, putatively non-aggregating MBP-Apoptin construct.
We inspected the morphological appearance of the two expressed construct in intact cells by immunofluorescence microscopy. Two days after transfection, a time point preceding significant apoptosis induction in this cell type, full-length MBP-Apoptin, was seen to form distinct globular particles in the cytoplasm and nucleus of Saos-2 cells (Fig. 6A) . Most strikingly, a large proportion of the protein accumulated at the nuclear rim, which may be caused by "congestion" of MBPApoptin particles at or in the nuclear pores. In contrast, MBPApoptin(80 -121) had a much more diffuse appearance and was predominantly located in the nucleus (Fig. 6A) . We observed essentially the same distribution in HeLa cells (data not shown). These results suggest that full-length MBP-Apoptin becomes aggregated in tumor cells, whereas MBP-Apoptin(80 -121) does not. Moreover, these results confirm that MBP itself does not aggregate or contribute to the aggregation of its fusion partner, which is in accordance with the properties of bacterially expressed MBP-Apoptin fusion proteins.
In parallel, we determined the aggregation state of both protein constructs in cell extracts by centrifugation and found that the bulk of the extracted full-length MBP-Apoptin could be pelleted at 10,000 ϫ g, indicating that it is or is part of a very dense aggregate (Fig. 6B) . Moreover, most of the MBP-Apoptin that remained in the supernatant could be pelleted at 30,000 ϫ g. Under the same conditions, MBP-Apoptin(80 -121) was fully soluble (Fig. 6A) . Moreover, we verified that recombinant MBPApoptin alone did not precipitate upon dilution in lysis buffer (Fig. 6C) . We assume that the trace amount of full-length MBP-Apoptin remaining in the supernatant after centrifugation at 30,000 ϫ g corresponds to newly translated polypeptides that were not yet fully aggregated or had been absorbed by detergent micelles. Taken together with the immunofluorescence data, these results imply that aggregation of Apoptin occurs in vivo and that the determinants responsible for aggregation are located in the N-terminal part of the protein.
The Recombinant MBP-Apoptin Protein Complex Is Active as a Multimeric Species
In a separate paper, we show that microinjected recombinant MBP-Apoptin protein induces apoptosis in tumor Saos-2 cells, but not in normal VH10 cells. 3 This observation prompted us to examine the role of aggregation of recombinant MBP-Apoptin in apoptosis induction.
We established that recombinant Apoptin aggregates were not dissolved by cellular factors in vitro under physiologically relevant conditions; neither VH10 nor Saos-2 cell lysate affected the size distribution of MBP-Apoptin aggregates in the presence of ATP and Mg 2ϩ , as tested by size exclusion chromatography (data not shown). Furthermore, in both Saos-2 and VH10 samples, the characteristic degradation pattern of MBPApoptin remained unchanged upon incubation and fractionation. A small amount of untagged Apoptin was present in the starting material, and it remained associated with the intact fusion protein without any changes in ratio (data not shown).
Next, to ensure that MBP-Apoptin aggregates did not dissolve upon microinjection into living cells, we cross-linked the MBP-Apoptin aggregates by brief incubation with 0.05% glutaraldehyde. The majority of these cross-links are expected to be between the MBP moieties if the multimeric fusion protein, as they contain most of the Lys residues. Cross-linked complexes did not contain detectable amounts of smaller oligomers or monomers (Fig. 7A) . DLS analysis of cross-linked MBP-Apoptin confirmed the presence of a single particle with an R H of 14.0 Ϯ 1.5 nm. First, this finding demonstrated that crosslinking caused the MBP-Apoptin complex to become more compact. Second, it showed that nearly all cross-linking occurred within complexes, with a negligible number of linkages between different complexes being formed. To follow the fate of MBP-Apoptin complexes upon microinjection, the fluorescent label fluorescein-5-maleimide was attached to Apoptin's single solvent-exposed Cys residue prior to glutaraldehyde cross-linking. When microinjected into the cytoplasm of Saos-2 cells, the fluorescein-labeled, cross-linked MBP-Apoptin was imported into the nucleus and induced the same level of apoptosis within 24 h as non-cross-linked MBP-Apoptin (Fig. 7, B and C) . However, the efficiency of nuclear import of cross-linked MBPApoptin appeared to be decreased in comparison to non-crosslinked MBP-Apoptin (data not shown), 3 which may indicate that some of its nuclear localization signals are obscured as a result of glutaraldehyde treatment. In VH10 cells, cross-linked MBP-Apoptin remained in the cytoplasm and did not induce apoptosis (Fig. 7, B and D) . Clearly, covalent cross-linking did not have any significant effect on the activity of microinjected MBP-Apoptin, implying that in vivo dissociation of the recombinant Apoptin protein multimers is not required for tumorspecific apoptosis induction. linker between MBP and Apoptin in the MBP-Apoptin fusion protein increased its hydrodynamic radius, leading to an overestimation of its molecular mass. When MBP-Apoptin complexes were cross-linked with glutaraldehyde, they became more compact as judged by DLS, presumably because the MBP moieties became firmly attached to each other and to the body of the Apoptin core. On the basis of its hydrodynamic radius, the theoretical molecular mass of the cross-linked MBP-Apoptin complex is 1.6 MDa, corresponding to 30 monomeric subunits. This is fully consistent with the monomer content of refolded Apoptin-H 6 we observed.
CD spectroscopy indicated that Apoptin protein multimers contain little if any secondary structure, which may reflect a lack of internal ordering. This result raises the question of how a seemingly disordered Apoptin polypeptide can assemble into a biologically active and homogenous protein multimer. We hypothesize that Apoptin multimers consist of only a limited number of monomer conformations. Our experimental results on recombinant Apoptin protein support such an idea. First, we demonstrated that Apoptin's Tyr 95 forms a stable hydrogen bond, which implies that there is at least some internal structure. Second, the CD spectrum of refolded Apoptin-H 6 was clearly different from that of a true random coil polypeptide, indicating that its conformational freedom was restricted (11) . If Apoptin multimers present an at least partially ordered surface, this characteristic would allow them to interact selectively with cellular factors. Such an interaction could give rise to a particular biological effect, namely the induction of apoptosis in a tumor-specific manner. Furthermore, it could be that small domains of the Apoptin multimer become ordered once recognized by cellular factors. There are precedents for such behavior; for example, high mobility group proteins specifically recognize DNA, yet in the absence of DNA do not adopt a regular conformation (27 ). However, we showed that this configuration of Cys and His residues did not constitute a Zn 2ϩ -binding site in recombinant Apoptin. If this sequence indeed adopts a ␤-hairpin-type conformation, the large hydrophobic residues would all protrude from one of the faces of the hairpin, whereas the hydrophilic residues would protrude from the other. Such an amphipathic motif could well be essential for the multimerization properties of Apoptin, perhaps by allowing the Leu and Ile residues of neighboring Apoptin monomers to interlock. Our observation that the presence of OG caused MBP-Apoptin to precipitate does suggest that the multimerization of Apoptin is, at least to an extent, based on hydrophobic interactions. It may be that OG is more effective than CHAPSO and Triton in disrupting Apoptin multimers because of its small size and high micelle concentration (ϳ9 mM or ϳ0.3%), allowing it to penetrate the Apoptin core of MBP-Apoptin.
The Leu/Ile clustering of the potential amphipathic ␤-hairpin is reminiscent of a Rev-or PKI␣Ϫlike nuclear export signal (NES) (28) . Although the NES sequences of PKI␣ and of p53 have been reported to adopt an amphipathic ␣-helical conformation (29, 30) , CD spectroscopy showed that refolded Apoptin-H 6 did not contain any ␣-helical regions. If indeed the isoleucines and leucines of the putative NES of Apoptin are part of its multimerization motif, these residues would, because of their hydrophobic nature, be largely buried within the multimer. Thus obscured, Apoptin's putative NES would be likely to have reduced activity.
Activity of the Apoptin Complex-We established that ectopically expressed, full-length MBP-Apoptin was aggregated in live tumor cells, whereas truncated MBP-Apoptin(80 -121) was not. This difference in aggregation state was consistent with our findings on recombinant MBP-Apoptin and truncated versions thereof. Moreover, the distribution of ectopically expressed MBP-Apoptin, including its accumulation at the nuclear envelope, was similar to that of the recombinant protein following microinjection. 3 Furthermore, the size of the aggregates formed by full-length MBP-Apoptin in vivo was remarkably regular. Such homogeneity is strongly reminiscent of the narrow size distribution of bacterially expressed MBP-Apoptin. However, ectopically expressed MBP-Apoptin was contained in an aggregate particle that was denser than the recombinant Apoptin protein multimer. Therefore, it is likely that Apoptin expressed in vivo forms a larger aggregate or co-aggregates with other cellular proteins.
Our results suggest that aggregation of Apoptin in vivo does not preclude induction of apoptosis, which would imply that Apoptin does not have to be a properly folded molecule to be active. Moreover, as most if not all ectopically expressed MBPApoptin was found to be aggregated, it is very likely that this aggregated state represents the physiological form of Apoptin in tumor cells. Alternatively, it is possible that the protein undergoes a transition between a folded and an unfolded state in vivo upon binding to some cellular factor. We expect that an inducible Apoptin expression system in human tumor cells will 
